You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTCH1

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-melanoma Skin Cancer Trial in Birmingham (Solaraze and Vaniqa)

Recruiting
  • Non-melanoma Skin Cancer
  • Solaraze and Vaniqa
  • Birmingham, Alabama
  • +1 more
Nov 14, 2022

Barrett Oesophagitis With Dysplasia Trial in Kansas City (Itraconazole in capsule form, Itraconazole in solution form)

Recruiting
  • Barrett Oesophagitis With Dysplasia
  • Itraconazole in capsule form
  • Itraconazole in solution form
  • Kansas City, Kansas
    University of Kansas Medical Center
Nov 1, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

NSCLC Trial in Dallas (Itraconazole)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Dallas, Texas
    UT Southwestern Medical Center
Apr 7, 2021

Carcinoma, Basal Cell Trial in United States (CX-4945)

Recruiting
  • Carcinoma, Basal Cell
  • Aurora, Colorado
  • +3 more
Mar 11, 2022

Germline Mutations Associated With Hereditary Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Invitae Multi-Cancer Panel ®
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Mar 22, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Basal Cell Nevus Syndrome Trial (Vismodegib, Nivolumab, Ipilimumab)

Withdrawn
  • Basal Cell Nevus Syndrome
  • (no location specified)
Dec 16, 2019

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

Recruiting
  • Intracranial Meningioma
  • +2 more
  • Birmingham, Alabama
  • +707 more
Sep 25, 2022

The Biomarker Analysis in Locally Advanced Cervical Cancer

Active, not recruiting
  • Uterine Cervical Neoplasms
    • Taipei, Taiwan
      Mackay Memorial Hospital
    Aug 15, 2018

    Carcinoma, Basal Cell, Recurrent Skin Cancer, Skin Tumors Trial in Stanford (Buparlisib, Sonidegib)

    Terminated
    Has Results
    • Carcinoma, Basal Cell
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Jan 10, 2019

    Advanced Breast Cancer Trial in Spain (LDE225, Docetaxel)

    Completed
    Has Results
    • Advanced Breast Cancer
    • A Coruña, Spain
    • +4 more
    Dec 3, 2018

    Prostate Cancer Trial in Baltimore (Vismodegib)

    Completed
    Has Results
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Oct 5, 2017

    PTCH1 or SMO Activated Solid and Hematologic Tumors Trial in United States (LDE225)

    Terminated
    Has Results
    • PTCH1 or SMO Activated Solid and Hematologic Tumors
    • Sacramento, California
    • +9 more
    Apr 25, 2016

    Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +80 more
    Feb 19, 2020

    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (drug, procedure, other)

    Completed
    Has Results
    • Adult Giant Cell Glioblastoma
    • +3 more
    • Los Angeles, California
    • +8 more
    Aug 15, 2017

    Adult Medulloblastoma Trial in United States (Pharmacological Study, Vismodegib)

    Completed
    Has Results
    • Adult Medulloblastoma
    • Los Angeles, California
    • +12 more
    Jan 28, 2016

    Breast Tumors Trial (Erismodegib, Placebo)

    Withdrawn
    • Breast Neoplasms
    • (no location specified)
    Apr 24, 2015

    Confrontation Phenotypes and Genotypes of Epithelial Odontogenic

    Completed
    • Epithelial Odontogenic Tumours
      • Paris, France
        Stomatologie et Chirurgie Maxillofaciale - Pitie Salpetriere
      Apr 23, 2015

      Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Baltimore, Ann Arbor, Detroit

      Terminated
      • Estrogen Receptor Negative
      • +7 more
      • Gamma-Secretase Inhibitor RO4929097
      • +4 more
      • Baltimore, Maryland
      • +2 more
      Apr 14, 2015

      Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,

      Completed
      Has Results
      • Adenocarcinoma of the Pancreas
      • +2 more
      • Beverly Hills, California
      • +25 more
      Jul 20, 2015

      Basal Cell Carcinoma Trial in Maastricht (Diclofenac, Diclofenac + Calcitriol, Calcitriol)

      Completed
      • Basal Cell Carcinoma
      • Maastricht, Limburg, Netherlands
        Maastricht University Medical Center
      Jan 12, 2015